Breaking through an epigenetic wall

References

• Sterneckert J, Höing S, Schöler HR. Concise review: Oct4 and more: the reprogramming expressway. Stem Cells 2012; 30:15 - 21; http://dx.doi.org/10.1002/stem.765; PMID: 22009686
   PubMed Web of Science ®Google Scholar
• Walker E, Ohishi M, Davey RE, Zhang W, Cassar PA, Tanaka TS, et al. Prediction and testing of novel transcriptional networks regulating embryonic stem cell self-renewal and commitment. Cell Stem Cell 2007; 1:71 - 86; http://dx.doi.org/10.1016/j.stem.2007.04.002; PMID: 18371337
   PubMed Web of Science ®Google Scholar
• Liang J, Wan M, Zhang Y, Gu P, Xin H, Jung SY, et al. Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. Nat Cell Biol 2008; 10:731 - 9; http://dx.doi.org/10.1038/ncb1736; PMID: 18454139
   PubMed Web of Science ®Google Scholar
• Pardo M, Lang B, Yu L, Prosser H, Bradley A, Babu MM, et al. An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. Cell Stem Cell 2010; 6:382 - 95; http://dx.doi.org/10.1016/j.stem.2010.03.004; PMID: 20362542
   PubMed Web of Science ®Google Scholar
• Wang J, Rao S, Chu J, Shen X, Levasseur DN, Theunissen TW, et al. A protein interaction network for pluripotency of embryonic stem cells. Nature 2006; 444:364 - 8; http://dx.doi.org/10.1038/nature05284; PMID: 17093407
   PubMed Web of Science ®Google Scholar
• Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005; 122:947 - 56; http://dx.doi.org/10.1016/j.cell.2005.08.020; PMID: 16153702
   PubMed Web of Science ®Google Scholar
• Babaie Y, Herwig R, Greber B, Brink TC, Wruck W, Groth D, et al. Analysis of Oct4-dependent transcriptional networks regulating self-renewal and pluripotency in human embryonic stem cells. Stem Cells 2007; 25:500 - 10; http://dx.doi.org/10.1634/stemcells.2006-0426; PMID: 17068183
   PubMed Web of Science ®Google Scholar
• Feldman N, Gerson A, Fang J, Li E, Zhang Y, Shinkai Y, et al. G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat Cell Biol 2006; 8:188 - 94; http://dx.doi.org/10.1038/ncb1353; PMID: 16415856
   PubMed Web of Science ®Google Scholar
• Gu P, Xu X, Le Menuet D, Chung AC, Cooney AJ. Differential recruitment of methyl CpG-binding domain factors and DNA methyltransferases by the orphan receptor germ cell nuclear factor initiates the repression and silencing of Oct4. Stem Cells 2011; 29:1041 - 51; http://dx.doi.org/10.1002/stem.652; PMID: 21608077
   PubMed Web of Science ®Google Scholar
• Dyce PW, Toms D, Li J. Stem cells and germ cells: microRNA and gene expression signatures. Histol Histopathol 2010; 25:505 - 13; PMID: 20183803
   PubMed Web of Science ®Google Scholar
• Hassiotou F, Beltran A, Chetwynd E, Stuebe AM, Twigger AJ, Metzger P, et al. Breastmilk is a novel source of stem cells with multilineage differentiation potential. Stem Cells 2012; 30:2164 - 74; http://dx.doi.org/10.1002/stem.1188; PMID: 22865647
   PubMed Web of Science ®Google Scholar
• Beltran AS, Rivenbark AG, Richardson BT, Yuan X, Quian H, Hunt JP, et al. Generation of tumor-initiating cells by exogenous delivery of OCT4 transcription factor. Breast Cancer Res 2011; 13:R94; http://dx.doi.org/10.1186/bcr3019; PMID: 21952072
   PubMedGoogle Scholar
• Latifi A, Luwor RB, Bilandzic M, Nazaretian S, Stenvers K, Pyman J, et al. Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors. PLoS One 2012; 7:e46858; http://dx.doi.org/10.1371/journal.pone.0046858; PMID: 23056490
   PubMed Web of Science ®Google Scholar
• Zhang J, Li YL, Zhou CY, Hu YT, Chen HZ. Expression of octamer-4 in serous and mucinous ovarian carcinoma. J Clin Pathol 2010; 63:879 - 83; http://dx.doi.org/10.1136/jcp.2009.073593; PMID: 20876318
   PubMed Web of Science ®Google Scholar
• Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:861 - 72; http://dx.doi.org/10.1016/j.cell.2007.11.019; PMID: 18035408
   PubMed Web of Science ®Google Scholar
• Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126:663 - 76; http://dx.doi.org/10.1016/j.cell.2006.07.024; PMID: 16904174
   PubMed Web of Science ®Google Scholar
• Kim JB, Greber B, Araúzo-Bravo MJ, Meyer J, Park KI, Zaehres H, et al. Direct reprogramming of human neural stem cells by OCT4. Nature 2009; 461:649 - 3; http://dx.doi.org/10.1038/nature08436; PMID: 19718018
   PubMed Web of Science ®Google Scholar
• Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007; 448:318 - 24; http://dx.doi.org/10.1038/nature05944; PMID: 17554336
   PubMed Web of Science ®Google Scholar
• Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, et al. Epigenetic memory in induced pluripotent stem cells. Nature 2010; 467:285 - 90; http://dx.doi.org/10.1038/nature09342; PMID: 20644535
   PubMed Web of Science ®Google Scholar
• Lister R, Pelizzola M, Kida YS, Hawkins RD, Nery JR, Hon G, et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 2011; 471:68 - 73; http://dx.doi.org/10.1038/nature09798; PMID: 21289626
   PubMed Web of Science ®Google Scholar
• Shi Y, Desponts C, Do JT, Hahm HS, Schöler HR, Ding S. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 2008; 3:568 - 74; http://dx.doi.org/10.1016/j.stem.2008.10.004; PMID: 18983970
   PubMed Web of Science ®Google Scholar
• Feng B, Ng JH, Heng JC, Ng HH. Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell 2009; 4:301 - 12; http://dx.doi.org/10.1016/j.stem.2009.03.005; PMID: 19341620
   PubMed Web of Science ®Google Scholar
• Huangfu D, Osafune K, Maehr R, Guo W, Eijkelenboom A, Chen S, et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 2008; 26:1269 - 75; http://dx.doi.org/10.1038/nbt.1502; PMID: 18849973
   PubMed Web of Science ®Google Scholar
• Doege CA, Inoue K, Yamashita T, Rhee DB, Travis S, Fujita R, et al. Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2. Nature 2012; 488:652 - 5; http://dx.doi.org/10.1038/nature11333; PMID: 22902501
   PubMed Web of Science ®Google Scholar
• Bhutani N, Brady JJ, Damian M, Sacco A, Corbel SY, Blau HM. Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature 2010; 463:1042 - 7; http://dx.doi.org/10.1038/nature08752; PMID: 20027182
   PubMed Web of Science ®Google Scholar
• Bultmann S, Morbitzer R, Schmidt CS, Thanisch K, Spada F, Elsaesser J, et al. Targeted transcriptional activation of silent oct4 pluripotency gene by combining designer TALEs and inhibition of epigenetic modifiers. Nucleic Acids Res 2012; 40:5368 - 77; http://dx.doi.org/10.1093/nar/gks199; PMID: 22387464
   PubMed Web of Science ®Google Scholar
• Beltran AS, Blancafort P. Remodeling genomes with artificial transcription factors (ATFs). Methods Mol Biol 2010; 649:163 - 82; http://dx.doi.org/10.1007/978-1-60761-753-2_10; PMID: 20680834
   PubMedGoogle Scholar
• de Groote ML, Verschure PJ, Rots MG. Epigenetic Editing: targeted rewriting of epigenetic marks to modulate expression of selected target genes. Nucleic Acids Res 2012; 40:10596 - 613; http://dx.doi.org/10.1093/nar/gks863; PMID: 23002135
   PubMed Web of Science ®Google Scholar
• Blancafort P, Segal DJ, Barbas CF 3rd. Designing transcription factor architectures for drug discovery. Mol Pharmacol 2004; 66:1361 - 71; http://dx.doi.org/10.1124/mol.104.002758; PMID: 15340042
   PubMed Web of Science ®Google Scholar
• Beltran AS, Blancafort P. Reactivation of MASPIN in non-small cell lung carcinoma (NSCLC) cells by artificial transcription factors (ATFs). Epigenetics 2011; 6:224 - 35; http://dx.doi.org/10.4161/epi.6.2.13700; PMID: 20948306
   PubMed Web of Science ®Google Scholar
• Beltran A, Parikh S, Liu Y, Cuevas BD, Johnson GL, Futscher BW, et al. Re-activation of a dormant tumor suppressor gene maspin by designed transcription factors. Oncogene 2007; 26:2791 - 8; http://dx.doi.org/10.1038/sj.onc.1210072; PMID: 17057734
   PubMed Web of Science ®Google Scholar
• Beltran AS, Russo A, Lara H, Fan C, Lizardi PM, Blancafort P. Suppression of breast tumor growth and metastasis by an engineered transcription factor. PLoS One 2011; 6:e24595; http://dx.doi.org/10.1371/journal.pone.0024595; PMID: 21931769
   PubMedGoogle Scholar
• Lara H, Wang Y, Beltran AS, Juárez-Moreno K, Yuan X, Kato S, et al. Targeting serous epithelial ovarian cancer with designer zinc finger transcription factors. J Biol Chem 2012; 287:29873 - 86; http://dx.doi.org/10.1074/jbc.M112.360768; PMID: 22782891
   PubMed Web of Science ®Google Scholar
• Beltran AS, Sun X, Lizardi PM, Blancafort P. Reprogramming epigenetic silencing: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor. Mol Cancer Ther 2008; 7:1080 - 90; http://dx.doi.org/10.1158/1535-7163.MCT-07-0526; PMID: 18483297
   PubMed Web of Science ®Google Scholar
• Sera T. Zinc-finger-based artificial transcription factors and their applications. Adv Drug Deliv Rev 2009; 61:513 - 26; http://dx.doi.org/10.1016/j.addr.2009.03.012; PMID: 19394375
   PubMed Web of Science ®Google Scholar
• Blancafort P, Beltran AS. Rational design, selection and specificity of artificial transcription factors (ATFs): the influence of chromatin in target gene regulation. Comb Chem High Throughput Screen 2008; 11:146 - 58; http://dx.doi.org/10.2174/138620708783744453; PMID: 18336208
   PubMed Web of Science ®Google Scholar
• Stolzenburg S, Rots MG, Beltran AS, Rivenbark AG, Yuan X, Qian H, et al. Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer. Nucleic Acids Res 2012; 40:6725 - 40; http://dx.doi.org/10.1093/nar/gks360; PMID: 22561374
   PubMed Web of Science ®Google Scholar
• Rivenbark AG, Stolzenburg S, Beltran AS, Yuan X, Rots MG, Strahl BD, et al. Epigenetic reprogramming of cancer cells via targeted DNA methylation. Epigenetics 2012; 7:350 - 60; http://dx.doi.org/10.4161/epi.19507; PMID: 22419067
   PubMed Web of Science ®Google Scholar
• Iyengar S, Farnham PJ. KAP1 protein: an enigmatic master regulator of the genome. J Biol Chem 2011; 286:26267 - 76; http://dx.doi.org/10.1074/jbc.R111.252569; PMID: 21652716
   PubMed Web of Science ®Google Scholar
• Iyengar S, Ivanov AV, Jin VX, Rauscher FJ 3rd, Farnham PJ. Functional analysis of KAP1 genomic recruitment. Mol Cell Biol 2011; 31:1833 - 47; http://dx.doi.org/10.1128/MCB.01331-10; PMID: 21343339
   PubMed Web of Science ®Google Scholar
• Frietze S, Lan X, Jin VX, Farnham PJ. Genomic targets of the KRAB and SCAN domain-containing zinc finger protein 263. J Biol Chem 2010; 285:1393 - 403; http://dx.doi.org/10.1074/jbc.M109.063032; PMID: 19887448
   PubMed Web of Science ®Google Scholar
• Meilinger D, Fellinger K, Bultmann S, Rothbauer U, Bonapace IM, Klinkert WE, et al. Np95 interacts with de novo DNA methyltransferases, Dnmt3a and Dnmt3b, and mediates epigenetic silencing of the viral CMV promoter in embryonic stem cells. EMBO Rep 2009; 10:1259 - 64; http://dx.doi.org/10.1038/embor.2009.201; PMID: 19798101
   PubMed Web of Science ®Google Scholar
• Epsztejn-Litman S, Feldman N, Abu-Remaileh M, Shufaro Y, Gerson A, Ueda J, et al. De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes. Nat Struct Mol Biol 2008; 15:1176 - 83; http://dx.doi.org/10.1038/nsmb.1476; PMID: 18953337
   PubMed Web of Science ®Google Scholar
• Hochedlinger K, Plath K. Epigenetic reprogramming and induced pluripotency. Development 2009; 136:509 - 23; http://dx.doi.org/10.1242/dev.020867; PMID: 19168672
   PubMed Web of Science ®Google Scholar
• Kim JB, Zaehres H, Wu G, Gentile L, Ko K, Sebastiano V, et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 2008; 454:646 - 50; http://dx.doi.org/10.1038/nature07061; PMID: 18594515
   PubMed Web of Science ®Google Scholar
• Kobolak J, Kiss K, Polgar Z, Mamo S, Rogel-Gaillard C, Tancos Z, et al. Promoter analysis of the rabbit POU5F1 gene and its expression in preimplantation stage embryos. BMC Mol Biol 2009; 10:88; http://dx.doi.org/10.1186/1471-2199-10-88; PMID: 19732419
   PubMed Web of Science ®Google Scholar
• Beerli RR, Segal DJ, Dreier B, Barbas CF 3rd. Toward controlling gene expression at will: specific regulation of the erbB-2/HER-2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks. Proc Natl Acad Sci U S A 1998; 95:14628 - 33; http://dx.doi.org/10.1073/pnas.95.25.14628; PMID: 9843940
   PubMed Web of Science ®Google Scholar
• Urrutia R. KRAB-containing zinc-finger repressor proteins. Genome Biol 2003; 4:231; http://dx.doi.org/10.1186/gb-2003-4-10-231; PMID: 14519192
   PubMed Web of Science ®Google Scholar
• Collins T, Stone JR, Williams AJ. All in the family: the BTB/POZ, KRAB, and SCAN domains. Mol Cell Biol 2001; 21:3609 - 15; http://dx.doi.org/10.1128/MCB.21.11.3609-3615.2001; PMID: 11340155
   PubMed Web of Science ®Google Scholar
• Peng S, Maihle NJ, Huang Y. Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer. Oncogene 2010; 29:2153 - 9; http://dx.doi.org/10.1038/onc.2009.500; PMID: 20101213
   PubMed Web of Science ®Google Scholar
• Topisirovic I, Kentsis A, Perez JM, Guzman ML, Jordan CT, Borden KL. Eukaryotic translation initiation factor 4E activity is modulated by HOXA9 at multiple levels. Mol Cell Biol 2005; 25:1100 - 12; http://dx.doi.org/10.1128/MCB.25.3.1100-1112.2005; PMID: 15657436
   PubMed Web of Science ®Google Scholar
• Tachibana M, Matsumura Y, Fukuda M, Kimura H, Shinkai Y. G9a/GLP complexes independently mediate H3K9 and DNA methylation to silence transcription. EMBO J 2008; 27:2681 - 90; http://dx.doi.org/10.1038/emboj.2008.192; PMID: 18818694
   PubMed Web of Science ®Google Scholar
• Hu T, Liu S, Breiter DR, Wang F, Tang Y, Sun S. Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis. Cancer Res 2008; 68:6533 - 40; http://dx.doi.org/10.1158/0008-5472.CAN-07-6642; PMID: 18701476
   PubMed Web of Science ®Google Scholar
• Gao MQ, Choi YP, Kang S, Youn JH, Cho NH. CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells. Oncogene 2010; 29:2672 - 80; http://dx.doi.org/10.1038/onc.2010.35; PMID: 20190812
   PubMed Web of Science ®Google Scholar
• Hu L, McArthur C, Jaffe RB. Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant. Br J Cancer 2010; 102:1276 - 83; http://dx.doi.org/10.1038/sj.bjc.6605626; PMID: 20354527
   PubMed Web of Science ®Google Scholar
• Samardzija C, Quinn M, Findlay JK, Ahmed N. Attributes of Oct4 in stem cell biology: perspectives on cancer stem cells of the ovary. J Ovarian Res 2012; 5:37; http://dx.doi.org/10.1186/1757-2215-5-37; PMID: 23171809
   PubMed Web of Science ®Google Scholar
• Mak VC, Siu MK, Wong OG, Chan KK, Ngan HY, Cheung AN. Dysregulated stemness-related genes in gynecological malignancies. Histol Histopathol 2012; 27:1121 - 30; PMID: 22806899
   PubMed Web of Science ®Google Scholar
• Park JT, Chen X, Tropè CG, Davidson B, Shih IeM, Wang TL. Notch3 overexpression is related to the recurrence of ovarian cancer and confers resistance to carboplatin. Am J Pathol 2010; 177:1087 - 94; http://dx.doi.org/10.2353/ajpath.2010.100316; PMID: 20671266
   PubMed Web of Science ®Google Scholar
• Gentilini O, Masullo M, Rotmensz N, Peccatori F, Mazzarol G, Smeets A, et al. Breast cancer diagnosed during pregnancy and lactation: biological features and treatment options. Eur J Surg Oncol 2005; 31:232 - 6; http://dx.doi.org/10.1016/j.ejso.2004.11.012; PMID: 15780556
   PubMed Web of Science ®Google Scholar
• Keleher AJ, Theriault RL, Gwyn KM, Hunt KK, Stelling CB, Singletary SE, et al. Multidisciplinary management of breast cancer concurrent with pregnancy. J Am Coll Surg 2002; 194:54 - 64; http://dx.doi.org/10.1016/S1072-7515(01)01105-X; PMID: 11800340
   PubMed Web of Science ®Google Scholar
• Schultz DC, Ayyanathan K, Negorev D, Maul GG, Rauscher FJ 3rd. SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev 2002; 16:919 - 32; http://dx.doi.org/10.1101/gad.973302; PMID: 11959841
   PubMed Web of Science ®Google Scholar
• Yu HB, Kunarso G, Hong FH, Stanton LW. Zfp206, Oct4, and Sox2 are integrated components of a transcriptional regulatory network in embryonic stem cells. J Biol Chem 2009; 284:31327 - 35; http://dx.doi.org/10.1074/jbc.M109.016162; PMID: 19740739
   PubMed Web of Science ®Google Scholar
• Zaret KS, Carroll JS. Pioneer transcription factors: establishing competence for gene expression. Genes Dev 2011; 25:2227 - 41; http://dx.doi.org/10.1101/gad.176826.111; PMID: 22056668
   PubMed Web of Science ®Google Scholar
• Wang ZX, Teh CH, Chan CM, Chu C, Rossbach M, Kunarso G, et al. The transcription factor Zfp281 controls embryonic stem cell pluripotency by direct activation and repression of target genes. Stem Cells 2008; 26:2791 - 9; http://dx.doi.org/10.1634/stemcells.2008-0443; PMID: 18757296
   PubMed Web of Science ®Google Scholar
• Mandell JG, Barbas CF 3rd. Zinc Finger Tools: custom DNA-binding domains for transcription factors and nucleases. Nucleic Acids Res 2006; 34:Web Server issue W516-23; http://dx.doi.org/10.1093/nar/gkl209; PMID: 16845061
   PubMedGoogle Scholar